The Natural Choice for Bespoke Healthcare Compliance

The Natural Choice for Bespoke Health and Social Care Compliance

THE CQC'S NEW FRAMEWORK | Interpreting employee wellbeing and management statements

Class 2 Medicines Recall: USV UK Limited, Olopatadine USV 1mg/ml Eye Drops, Solution, EL(22)A/17

Published On:

11 April 2022

Published In:

USV UK Limited are recalling specific batches of products as a precautionary measure due to out of specification results for impurities during routine stability testing.

Company name

USV UK Limited

Product name

Olopatadine USV 1mg/mL eye drops, solution PL 32870/0055

Batch number Expiry date Pack size First distributed
35000201 07/2023 5ML 14 July 2021
35000202 07/2023 5ML 27 July 2021
35000203 07/2023 5ML 5 August 2021
35000204 07/2023 5ML 29 November 2021
35000206 07/2023 5ML 23 July 2021

Active Pharmaceutical Ingredient: Olopatadine hydrochloride

MDR number

MDR 209-03/22

Brief description of the problem

USV UK Limited are recalling the affected batches as a precautionary measure due to out of specification results for impurities during routine stability testing. The company’s investigation is on-going.

Advice for healthcare professionals

Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

Advice for patients

No further action is required by patients as this is a Pharmacy and Wholesaler level recall.

Although the Marketing Authorisation Holder have not received any reports of adverse reactions related to the issue above, patients who experience adverse reactions should seek immediate medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.

Further Information

For more information, medical or supply enquiries, please contact [email protected]

Recipients of this Medicines Recall should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.

For the full article and to download the document please click HERE

Request a Callback with Our Specialist Team!

Leave your contact details along with a few lines about the nature of your enquiry and a specialist member of our team will get in touch.

This website uses cookies to ensure you get the best experience on our website. Learn more

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors